Phase III trial shows new treatment boosts cure rate for most common form of breast cancer

by

A Peter Mac-led international clinical trial has shown adding an immunotherapy drug to the chemotherapy that patients receive ahead of surgery can dramatically improve breast cancer cure rates.

Leave A Comment

Your email address will not be published. Required fields are marked *